Every one of those 1 sits in a single category, earnings. GoodRx is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 12 original sources each against 4.7 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Kymera
Every one of those 1 sits in a single category, earnings. GoodRx is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 12 original sources each against 4.7 for the same window. At 5, the average consequence score sits below the same-window beat average of 6.5. We currently track 1 SaaS story that mention Kymera, all published on February 26, 2026.
Stories tracked
1
Sources per story
12
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 38 SaaS stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Kymera. Shared-story counts are live from our verified record — not editorial picks.
Payoneer Global Inc. reported Q4 2025 results that missed analyst expectations on both revenue and earnings, triggering a cautious market reaction. Despite the miss, the company signaled a major strategic shift by applying for a U.S. national bank charter and expanding into stablecoin-based cross-border settlements.
Kymera is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.